| 2008 JASN IMPACT FACTOR 7.505 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special Article |

* Department of Medicine, Charles Drew University, and
Department of Medicine, Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California
Correspondence: Dr. Keith C. Norris, Charles Drew University of Medicine and Science, 1731 East 120th Street, Los Angeles, CA 90059. Phone: 323-323-5702; Fax: 323-357–3486; E-mail: keithnorris{at}cdrewu.edu
Chronic kidney disease (CKD) is a national public health problem beset by inequities in incidence, prevalence, and complications across gender, race/ethnicity, and socioeconomic status. As health care providers, we can directly address some factors crucial for closing the disparities gap. Other factors are seemingly beyond our reach, entrenched within the fabric of our society, such as social injustice and human indifference. Paradoxically, the existence of health inequities provides unique, unrecognized opportunities for understanding biologic, environmental, sociocultural, and health care system factors that can lead to improved clinical outcomes. Several recent reports documented that structured medical care systems can reduce many CKD-related disparities and improve patient outcomes. Can the moral imperative to eliminate CKD inequities inspire the nephrology community not only to advocate for but also to demand high-quality, structured health care delivery systems for all Americans in the context of social reform that improves the ecology, health, and well-being of our communities? If so, then perhaps we can eliminate the unacceptable premature morbidity and mortality associated with CKD and the tragedy of health inequities. By so doing, we could become global leaders not only in medical technology, as we currently are, but also in health promotion and disease prevention, truly leaving no patient behind.
Related Articles
J. Am. Soc. Nephrol. 2008 19: 1249-1251.
J. Am. Soc. Nephrol. 2008 19: 1249-1251.
This article has been cited by other articles:
![]() |
D. M. Behar, S. Rosset, S. Tzur, S. Selig, G. Yudkovsky, S. Bercovici, J. B. Kopp, C. A. Winkler, G. W. Nelson, W. G. Wasser, et al. African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans Hum. Mol. Genet., February 9, 2010; (2010) ddq040v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Norris and L. Y. Agodoa How Long Can We Afford to Wait for Equity in the Renal Transplant Waiting List? J. Am. Soc. Nephrol., June 1, 2009; 20(6): 1168 - 1170. [Full Text] [PDF] |
||||
![]() |
L. A. Szczech, W. Harmon, T. H. Hostetter, P. E. Klotman, N. R. Powe, J. R. Sedor, P. Smedberg, and J. Himmelfarb World Kidney Day 2009: Problems and Challenges in the Emerging Epidemic of Kidney Disease J. Am. Soc. Nephrol., March 1, 2009; 20(3): 453 - 455. [Full Text] [PDF] |
||||
![]() |
D. E. Wesson Is the Ethnic Disparity in CKD a Symptom of Dysfunctional Primary Care in the US? J. Am. Soc. Nephrol., July 1, 2008; 19(7): 1249 - 1251. [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673